Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic

Sexually Transmitted Diseases

Volumn 35, Issue 7, 2008, Pages 679-685

  Gallo, Maria F ^a   Warner, Lee ^a   MacAluso, Maurizio ^a   Stone, Katherine M ^a   Brill, Ilene ^b   Fleenor, Michael E ^c   Hook, Edward W ^b,c   Austin, Harland D ^d   Lee, Francis K ^e   Nahmias, André J ^e  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CONDOM; CONDYLOMA ACUMINATUM; FEMALE; GONORRHEA; HERPES SIMPLEX VIRUS 2; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PROSPECTIVE STUDY; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UNITED STATES; VAGINITIS; VIRUS INFECTION; ADOLESCENT; BLOOD; COHORT ANALYSIS; EVALUATION; GENITAL HERPES; MALE; OUTPATIENT DEPARTMENT; PREVALENCE; SEX DIFFERENCE; UTILIZATION REVIEW; VIROLOGY;

ADOLESCENT; ADULT; ALABAMA; AMBULATORY CARE FACILITIES; COHORT STUDIES; CONDOMS; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; INCIDENCE; MALE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 50649112648     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31816fcaf8     Document Type: Article

References (54)

1. Nahmias AJ, Lee FK, Beckman-Nahmias S. The natural history and epidemiology of herpes simplex viruses (HSV). In: Studahl M, Cinque P, Bergstrom T, eds. Herpes Simplex Viruses. New York: Taylor and Francis, 2006:55-97.
2. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004; 11(suppl 1):24A-35A.
3. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296:964-973.
4. Brown ZA, Gardella C, Wald A, et al. Genital herpes complicating pregnancy. Obstet Gynecol 2005; 106:845-856.
5. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73-83.
6. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. J Infect Dis 2002; 185:45-52.
7. Nahmias AJ, Nahmias SB, Danielsson D. The possible role of transplacentally-acquired antibodies to infectious agents, with molecular mimicry to nervous system sialic acid epitopes, as causes of neuro-mental disorders: Prevention and vaccine implications. Clin Dev Immunol 2006; 13:167-183.
8. Tassiopoulos KK, Seage G 3rd, Sam N, et al. Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania. J Infect Dis 2007; 195:493-501.
9. Brown JM, Wald A, Hubbard A, et al. Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS 2007; 21:1515-1523.
10. Dickson N, van Roode T, Herbison P, et al. Risk of herpes simplex virus type 2 acquisition increases over early adulthood: Evidence from a cohort study. Sex Transm Infect 2007; 83:87-90.
11. Fife KH, Fortenberry JD, Ofner S, et al. Incidence and prevalence of herpes simplex virus infections in adolescent women. Sex Transm Dis 2006; 33:441-444.
12. Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143:707-713.
13. Gottlieb SL, Douglas JM Jr, Foster M, et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis 2004; 190:1059-1067.
14. Stanberry LR, Rosenthal SL, Mills L, et al. Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls. Clin Infect Dis 2004; 39:1433-1438.
15. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285:3100-3106.
16. Bunnell RE, Dahlberg L, Rolfs R, et al. High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors. J Infect Dis 1999; 180:1624-1631.
17. Langenberg AG, Corey L, Ashley RL, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341:1432-1438.
18. Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116:197-202.
19. Austin H, Macaluso M, Nahmias A, et al. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic. Sex Transm Dis 1999; 26:329-334.
20. Macaluso M, Artz L, Kelaghan J, et al. Prospective study of barrier contraception for the prevention of sexually transmitted diseases: Study design and general characteristics of the study group. Sex Transm Dis 1999; 26:127-136.
21. Artz L, Macaluso M, Meinzen-Derr J, et al. A randomized trial of clinician-delivered interventions promoting barrier contraception for sexually transmitted disease prevention. Sex Transm Dis 2005; 32: 672-679.
22. Centers for Disease Control and Prevention. 1989 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1989; 38:S-8.
23. Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1993; 42:1-102.
24. Shlay JC, McClung MW, Patnaik JL, et al. Comparison of sexually transmitted disease prevalence by reported level of condom use among patients attending an urban sexually transmitted disease clinic. Sex Transm Dis 2004; 31:154-160.
25. Lee FK, Coleman RM, Pereira L, et al. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol 1985; 22:641-644.
26. Lee FK, Pereira L, Griffin C, et al. A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. J Virol Methods 1986; 14:111-118.
27. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22.
28. Ashley RL, Militoni J, Lee F, et al. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988; 26:662-667.
29. Armstrong GL, Schillinger J, Markowitz L, et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001; 153:912-920.
30. Sizemore JM Jr, Lakeman F, Whitley R, et al. The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2006; 193:905-911.
31. Gottlieb SL, Douglas JM Jr, Schmid DS, et al. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis 2002; 186:1381-1389.
32. Nagot N, Ouedraogo A, Defer MC, et al. Association between bacterial vaginosis and Herpes simplex virus type-2 infection: Implications for HIV acquisition studies. 2007; 83:365-368.
33. Cherpes TL, Meyn LA, Krohn MA, et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003; 37:319-325.
34. Cherpes TL, Melan MA, Kant JA, et al. Genital tract shedding of herpes simplex virus type 2 in women: Effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 2005; 40:1422-1428.
35. Cherpes TL, Meyn LA, Krohn MA, et al. Risk factors for infection with herpes simplex virus type 2: Role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis 2003; 30:405-410.
36. Warner L, Stone KM, Macaluso M, et al. Condom use and risk of gonorrhea and Chlamydia: A systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis 2006; 33:36-51.
37. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004; 82:454-461.
38. Crosby RA, Sanders SA, Yarber WL, et al. Condom use errors and problems among college men. Sex Transm Dis 2002; 29:552-557.
39. Devine OJ, Aral SO. The impact of inaccurate reporting of condom use and imperfect diagnosis of sexually transmitted disease infection in studies of condom effectiveness: A simulation-based assessment. Sex Transm Dis 2004; 31:588-595.
40. Niccolai LM, Rowhani-Rahbar A, Jenkins H, et al. Condom effectiveness for prevention of Chlamydia trachomatis infection. Sex Transm Infect 2005; 81:323-325.
41. Warner L, Newman DR, Austin HD, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: The importance of assessing partner infection status. Am J Epidemiol 2004; 159: 242-251.
42. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. In: The Cochrane Library (CD-ROM). Issue 1. Oxford: Update Software, 2002.
43. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997; 44:1303-1312.
44. Maclure M. The case-crossover design: A method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133:144 -153.
45. Warner L, Macaluso M, Austin HD, et al. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol 2005; 161:765-773.
46. Centers for Disease Control and Prevention. 2006 Sexually transmitted diseases guidelines. MMWR Morb Mortal Wkly Rep 2006; 55:1-94.
47. Looker KJ, Garnett GP. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect 2005; 81:103-107.
48. Haddow LJ, Dave B, Mindel A, et al. Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003. Sex Transm Infect 2006; 82:255-259.
49. Nieuwenhuis RF, van Doornum GJ, Mulder PG, et al. Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes. Acta Derm Venereol 2006; 86:129-134.
50. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30:797-800.
51. Samra Z, Scherf E, Dan M. Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel. Sex Transm Dis 2003; 30:794-796.
52. Scoular A, Norrie J, Gillespie G, et al. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ 2002; 324:1366-1367.
53. Lafferty WE, Downey L, Celum C, et al. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000; 181:1454-1457.
54. Kimberlin DW, Rouse DJ. Clinical practice. Genital herpes. N Engl J Med 2004; 350:1970-1977.